Guidance on the use of International Nonproprietary Names (INNs)
for pharmaceutical substances
12 July 2017
| Publication

Overview
The present document on the use of INNs is intended as a general explanation of the INN selection process. They have been developed for drug regulatory authorities for use in the marketing authorization/registration of products, drug manufacturers who are requesting new INNs and those using INNs, patent authorities/offices, trademark attorneys and trademark specialists, scientists, teachers, health professionals, as well as any person interested in nomenclature.
WHO Team
INN and Classification of Medical Products (INN)
Number of pages
55